GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » HBM Healthcare Investments Ltd (XSWX:HBMN) » Definitions » Financial Strength

HBM Healthcare Investments (XSWX:HBMN) Financial Strength : 6 (As of Dec. 2023)


View and export this data going back to 2008. Start your Free Trial

What is HBM Healthcare Investments Financial Strength?

HBM Healthcare Investments has the Financial Strength Rank of 6.

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors:

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
2. Debt to revenue ratio. The lower, the better.
3. Altman Z-Score.

GuruFocus does not calculate HBM Healthcare Investments's interest coverage with the available data. HBM Healthcare Investments's debt to revenue ratio for the quarter that ended in Dec. 2023 was -0.29. Altman Z-Score does not apply to banks and insurance companies.


HBM Healthcare Investments Financial Strength Calculation

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

HBM Healthcare Investments's Interest Expense for the months ended in Dec. 2023 was CHF-0.33 Mil. Its Operating Income for the months ended in Dec. 2023 was CHF0.00 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was CHF99.34 Mil.

HBM Healthcare Investments's Interest Coverage for the quarter that ended in Dec. 2023 is

The higher the ratio, the stronger the company's financial strength is.

2. Debt to revenue ratio. The lower, the better.

HBM Healthcare Investments's Debt to Revenue Ratio for the quarter that ended in Dec. 2023 is

Debt to Revenue Ratio=Total Debt (Q: Dec. 2023 ) / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0 + 99.344) / -346.984
=-0.29

3. Altman Z-Score.

Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

The zones of discrimination were as such:

When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.

Altman Z-Score does not apply to banks and insurance companies.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HBM Healthcare Investments  (XSWX:HBMN) Financial Strength Explanation

The maximum rank is 10. Companies with rank 7 or higher will be unlikely to fall into distressed situations. Companies with rank of 3 or less are likely in financial distress.

HBM Healthcare Investments has the Financial Strength Rank of 6.


HBM Healthcare Investments Financial Strength Related Terms

Thank you for viewing the detailed overview of HBM Healthcare Investments's Financial Strength provided by GuruFocus.com. Please click on the following links to see related term pages.


HBM Healthcare Investments (XSWX:HBMN) Business Description

Traded in Other Exchanges
Address
Bundesplatz 1, Zug, CHE, 6300
HBM Healthcare Investments Ltd is a Switzerland-based holding company. The firm invests in the healthcare sector. It holds and manages an international portfolio of promising companies in the human medicine, biotechnology, medical technology and diagnostics sectors, and related areas.